Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Effect of a Clinical Decision Support System on Team-Based Clinical Quiz Performance Among Japanese Medical Students: A Pre-Post Pilot Study.

Journal of general and family medicine·2026
Same author

eIF4G2-mediated selective translation of chromatin regulators safeguards adult intestinal stem cell identity and differentiation.

Cell stem cell·2026
Same author

Temporal AI model predicts drivers of cell state trajectories across human aging.

bioRxiv : the preprint server for biology·2026
Same author

Shinya Yamanaka.

Cell reports. Medicine·2026
Same author

Two decades of induced pluripotent stem cell research: From discovery to diverse applications.

Cell stem cell·2026
Same author

Comparison of Myeloablative Busulfan/Cyclophosphamide and Busulfan/Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.

Transplantation and cellular therapy·2025

相关实验视频

Updated: Jun 24, 2026

Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids
10:52

Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids

Published on: June 5, 2015

对iPS细胞的新视角

Shinya Yamanaka1

  • 1Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan. yamanaka@frontier.kyoto-u.ac.jp

Cell
|April 7, 2009
PubMed
概括

诱导多能干细胞 (iPS) 对药物和制药具有巨大的潜力. 然而,必须克服重大挑战才能充分实现它们的治疗应用.

科学领域:

  • 干细胞生物学 干细胞生物学
  • 再生医学是一种再生医学.
  • 细胞重新编程的细胞重编程.

背景情况:

  • 诱导多能干细胞 (iPS) 为再生医学提供了一个有希望的途径.
  • 它们的潜在应用涵盖了各种治疗领域,包括疾病建模和药物发现.
  • 显著的障碍阻碍了将iPS细胞技术转化为临床实践.

研究的目的:

  • 探索诱导多能干细胞 (iPS) 的巨大潜力.
  • 识别和分析阻碍iPS细胞医学和制药应用的关键障碍.
  • 为未来的治疗开发提供了解如何克服这些挑战.

主要方法:

  • 关于iPS细胞技术的当前文献的综述.
  • 对在iPS细胞生成,分化和安全方面报告的挑战进行分析.
  • 对不同重编程策略及其局限性的比较评估.

主要成果:

  • 在多个科学领域中,人们已经认识到iPS细胞的巨大潜力.
  • 确定的主要障碍包括重编程效率,遗传/表观遗传稳定性和瘤性.
  • 生产的可扩展性和协议的标准化仍然是制药应用的重大问题.

更多相关视频

Efficient Generation and Editing of Feeder-free IPSCs from Human Pancreatic Cells Using the CRISPR-Cas9 System
09:16

Efficient Generation and Editing of Feeder-free IPSCs from Human Pancreatic Cells Using the CRISPR-Cas9 System

Published on: November 8, 2017

Generation of Mice Derived from Induced Pluripotent Stem Cells
11:56

Generation of Mice Derived from Induced Pluripotent Stem Cells

Published on: November 29, 2012

相关实验视频

Last Updated: Jun 24, 2026

Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids
10:52

Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids

Published on: June 5, 2015

Efficient Generation and Editing of Feeder-free IPSCs from Human Pancreatic Cells Using the CRISPR-Cas9 System
09:16

Efficient Generation and Editing of Feeder-free IPSCs from Human Pancreatic Cells Using the CRISPR-Cas9 System

Published on: November 8, 2017

Generation of Mice Derived from Induced Pluripotent Stem Cells
11:56

Generation of Mice Derived from Induced Pluripotent Stem Cells

Published on: November 29, 2012

结论:

  • 诱导多能干细胞 (iPS) 是一种具有巨大潜力的变革性技术.
  • 克服与安全性,疗效和可扩展性相关的挑战对于临床翻译至关重要.
  • 进一步的研究和开发对于释放iPS细胞的全部医疗和制药效益至关重要.